Orbital ATK

134.50

0.0000

Volume:- -

Turnover:- -

Market Cap:7.78B

PE:22.39

High:134.50

Open:134.50

Low:134.50

Close:134.50

52wk High:134.59

52wk Low:95.84

Shares:57.83M

Float Shares:57.55M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):6.01

EPS(LYR):5.40

ROE:--

ROA:--

PB:4.15

PE(LYR):24.90

Loading ...

Overview Company News Filings

Concept

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Celularity Completes Strategic Review of 2023 Initiatives, Including Anticipated Biomaterials Production Ramp-Up and Pipeline Prioritization of Next-Generation Product Candidates

GlobeNewswire

·

Jan 26, 2023

Pacira BioSciences Reports Preliminary Net Product Sales of $57.5 Million for November 2022

GlobeNewswire

·

Dec 13, 2022

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/OA"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OA\",,,,,undefined,":{"symbol":"OA","market":"US","secType":"STK","nameCN":"Orbital ATK","latestPrice":134.5,"timestamp":1528401600000,"preClose":134.5,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":57547000,"shares":57827352,"eps":6.006955,"marketStatus":"Market Closed","change":0,"latestTime":"06-07 16:00:00 EDT","open":134.5,"high":134.5,"low":134.5,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":6.006955,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":134.5,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OA\",,,,,undefined,":{"symbol":"OA","floatShares":57547000,"roa":"--","roe":"--","lyrEps":5.402579,"shares":57827352,"dividePrice":0,"high":134.5,"amplitude":0,"preClose":134.5,"low":134.5,"week52Low":95.84,"pbRate":"4.15","week52High":134.59,"institutionHeld":0,"latestPrice":134.5,"eps":6.006955,"divideRate":0,"volume":0,"delay":0,"ttmEps":6.006955,"open":134.5,"prevYearClose":134.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2018-05-10","symbol":"OA","amount":0.32,"name":"Orbital ATK Inc","currency":"USD","type":"dividend","dateTimestamp":1525924800000},{"market":"US","date":"2018-05-03","symbol":"OA","fiscalQuarterEnding":"2018/03","expectedEps":1.5,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1525320000000,"reportTimeType":"pre","actualEps":1.76},{"market":"US","date":"2018-02-22","symbol":"OA","fiscalQuarterEnding":"2017/12","expectedEps":1.84,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1519275600000,"reportTimeType":"pre","actualEps":1.77},{"market":"US","date":"2018-02-09","symbol":"OA","amount":0.32,"name":"Orbital ATK Inc","currency":"USD","type":"dividend","dateTimestamp":1518152400000},{"market":"US","date":"2017-11-15","symbol":"OA","amount":0.32,"name":"Orbital ATK Inc","currency":"USD","type":"dividend","dateTimestamp":1510722000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OA\",market:\"US\",,,undefined,":[{"executeDate":"2017-03-07","recordDate":null,"paymentDate":null,"value":0.32,"currency":"USD"},{"executeDate":"2017-06-05","recordDate":null,"paymentDate":null,"value":0.32,"currency":"USD"},{"executeDate":"2017-09-01","recordDate":null,"paymentDate":null,"value":0.32,"currency":"USD"},{"executeDate":"2017-11-15","recordDate":null,"paymentDate":null,"value":0.32,"currency":"USD"},{"executeDate":"2018-02-09","recordDate":null,"paymentDate":null,"value":0.32,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OA\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2306192384","title":"Celularity Completes Strategic Review of 2023 Initiatives, Including Anticipated Biomaterials Production Ramp-Up and Pipeline Prioritization of Next-Generation Product Candidates","url":"https://stock-news.laohu8.com/highlight/detail?id=2306192384","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2306192384?lang=en_us&edition=fundamental","pubTime":"2023-01-26 21:17","pubTimestamp":1674739020,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2023/01/26/2596493/0/en/Celularity-Completes-Strategic-Review-of-2023-Initiatives-Including-Anticipated-Biomaterials-Production-Ramp-Up-and-Pipeline-Prioritization-of-Next-Generation-Product-Candidates.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","CAR","CAGR","NK","OA","BK4191","CRCT","IND","TERN","BK4007","BK4539"],"gpt_icon":0},{"id":"2291479093","title":"Pacira BioSciences Reports Preliminary Net Product Sales of $57.5 Million for November 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2291479093","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2291479093?lang=en_us&edition=fundamental","pubTime":"2022-12-13 13:00","pubTimestamp":1670907600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2022/12/13/2572674/0/en/Pacira-BioSciences-Reports-Preliminary-Net-Product-Sales-of-57-5-Million-for-November-2022.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4139","BK4535","OA","BK4568","BK4551","BNTX"],"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":14,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/OA\",params:#limit:6,delay:false,,,undefined,":[]}}